Products

Myo Plus
Otto Bock Healthcare Products
Patient Engagement & Education
Myo Plus by Ottobock is an FDA-cleared, AI-powered pattern recognition system for intuitive control of myoelectric upper-limb prostheses, utilizing muscle signals and a mobile app for personalized adaptation.

See all 1 product →

About Otto Bock Healthcare Products

Ottobock SE & Co. KGaA, commonly known as Ottobock, is a global medical technology company with a rich history spanning over a century, specializing in solutions that enhance mobility and quality of life for individuals with disabilities. For physicians, Ottobock is recognized as a world leader in prosthetics, offering advanced prosthetic limbs and components such as the microprocessor-controlled C-Leg and thought-controlled prostheses, which have set industry standards. The company also excels in orthotics, including neuro-orthotics, and provides a comprehensive range of wheelchairs and bionic exoskeletons designed for both rehabilitation and occupational use.

Beyond its core product portfolio, Ottobock is increasingly integrating artificial intelligence (AI) and digitalization into its offerings to further improve patient outcomes and streamline clinical workflows. This includes the development of myoelectric prostheses that leverage AI for consistent performance throughout the day, adapting to changes in the wearer’s residual limb and fatigue levels. Furthermore, Ottobock provides ‘smart documentation’ solutions for orthotics and prosthetics (O&P) professionals, utilizing AI-supported motion analysis to visualize device benefits and generate comprehensive reimbursement arguments, thereby enhancing efficiency in patient care and administrative processes. The company operates a global network of approximately 340 to 400 patient care centers and multiple research hubs, fostering innovation and personalized patient care worldwide.

Focus Areas

Prosthetics Orthotics Neuro-orthotics Wheelchairs Exoskeletons Digital Health AI for intuitive prosthesis control AI for treatment documentation AI for gait analysis Human-Machine Interface Digital Ergonomics

Business Intelligence

Key InvestorsNäder Holding
PartnershipsOnward Medical, Phantom Neuro, MotionMiners GmbH, University of Tübingen, Klinikum Traunstein
AcquisitionsSahva (2024), Brillinger (2023), Pace Rehabilitation (2023), SuitX (2021), EXOPULSE (2021), BionX Medical Technologies (2017), Respecta (2013), Neurodan (2005)
TechnologyCloud-based solutions, Smart sensors, AI-based analytics, 3D printing, Digital ecosystem (lifelounge), Microprocessor-controlled devices (C-Leg, Genium, C-Brace), MyoPlus pattern recognition
FDA ClearancesSuitX's Phoenix exoskeleton is FDA-approved. Phantom Neuro received Breakthrough Device Designation and TAP Designation from the U.S. Food and Drug Administration (FDA). cleared products (estimated)

Products by Otto Bock Healthcare Products

1 product in the directory

Myo Plus
Otto Bock Healthcare Products
Patient Engagement & Education
Myo Plus by Ottobock is an FDA-cleared, AI-powered pattern recognition system for intuitive control of myoelectric upper-limb prostheses, utilizing muscle signals and a mobile app for personalized adaptation.

What the Web Says

Ottobock is a global medical technology company specializing in prosthetics, orthotics, and mobility solutions, with a focus on improving quality of life through innovation and personalized patient care. Reviews for Ottobock products are generally positive, with users highlighting improved mobility, comfort, and a more natural feel. However, employer reviews present a mixed picture, with some employees praising the company culture and coworkers, while others express concerns about management, workload, and compensation.

Overall: Mixed

Strengths

  • Products offer improved mobility and a natural feel.
  • Excellent customer service and personalized care for patients.
  • Supportive and friendly coworkers.
  • Ability to learn new things and time/location flexibility for employees.
  • Good benefits (for some roles/locations).
  • Company has a clear sense of purpose in helping people.

Limitations

  • Management issues and unprofessionalism.
  • Unrealistic workload and expectations.
  • Low pay and concerns about benefits.
  • Slow and unreliable app connectivity for some prosthetic adjustments.
  • Some product liners can cause skin irritation during the breaking-in period.
  • Perceived shift in company focus towards revenue over employees.

Based on reviews from: Indeed.com, Reddit, YouTube, Fletchers Solicitors, Ottobock.care, SimplyHired, G2, Apple App Store, Dassault Systu00e8mes

Last updated: 2026-07-19

Videos

News, demos, and interviews about Otto Bock Healthcare Products.

Loading videos...

Videos load interactively. If none appear, search YouTube for Otto Bock Healthcare Products →

View all on YouTube

Press & Coverage

Ottobock Newsroom
Ottobock sells its Human Mobility wheelchair business
Ottobock is selling its Human Mobility wheelchair business to DHCare to sharpen its strategic focus on prosthetics and neuro-orthotics, with the transaction expected to close in the second half of 2026.
2026-06
EQS News
Ottobock continues strategic expansion of Neuro-Orthotics with acquisition
Ottobock is acquiring Fesia Technology, S.L., a Spanish company specializing in functional electrical stimulation (FES) systems, to expand its neuro-orthotics portfolio for neurological conditions.
2026-07
Fabbaloo
From Custom Prosthetics to Digital Care: Ottobock's Latest 3D Printing Innovation Signals a Healthcare Shift
Ottobock has unveiled 'iconiq', a 3D-printed silicone prosthetic liner customized for each patient using digital scans, representing a shift towards mass customization in healthcare manufacturing.
2026-06
Business Wire
Blue Arbor Technologies Announces Strategic Partnership with Ottobock and $5 Million Investment to Advance RESTOREu2122 Neuromuscular Interface System
Ottobock has invested $5 million in Blue Arbor Technologies to accelerate the development of the RESTOREu2122 Neuromuscular Interface System, a neurotechnology designed for intuitive prosthetic control.
2026-02
Ottobock Newsroom
Ottobock invests in Phantom Neuro's pioneering neurotechnology
Ottobock led a $19 million Series A funding round for Phantom Neuro, a neurotechnology company developing an intuitive human-machine interface for prosthetic control.
2025-04
Ottobock CA Shop
Ottobock launches new prosthetic foot and hydraulic knee joints for children
Ottobock has expanded its pediatric prosthetics range with the Maverick junior prosthetic foot and movido hydraulic knee joints, aiming to provide better mobility solutions for children with amputations and dysmelia.
2025-03
Ottobock Newsroom
EXPOLIFE 2025: Smarter treatment with Ottobock solutions
At EXPOLIFE 2025, Ottobock will showcase digital tools and innovations, including EasyScan technology and AI-supported 'smart documentation,' to enhance efficiency and patient care in orthopaedic workshops.
2025-03
PubMed
User preference and patient benefits of a novel energy storing and return foot: A randomized, cross-over clinical trial
A multicenter, randomized clinical trial evaluated the Ottobock Evanto, a novel energy-storing and return prosthetic foot, demonstrating user preference and benefits compared to other feet.
2024-12

Frequently Asked Questions

Ottobock integrates AI for intuitive prosthesis control, such as with Myo Plus pattern recognition for myoelectric arm prostheses, allowing for more natural and responsive movements. They also utilize AI for gait analysis and in their 'smart documentation' solution to simplify treatment documentation and generate personalized reimbursement justification letters, streamlining clinical workflows and improving efficiency. This digital ecosystem aims to connect patients and care providers for personalized support and optimized treatment.
Ottobock offers advanced prosthetic solutions like the C-Leg 4 and Genium microprocessor-controlled knees for natural gait, and the bebionic hand and speedhand with AI-powered pattern recognition for intuitive control. In orthotics, they provide functional devices for various conditions, including the C-Brace for real-time gait control and a comprehensive NeuroMobility portfolio. Their 'SUITX by Ottobock' exoskeletons, such as the IX BACK VOLTON, use AI and adaptive support to reduce physical strain and enhance workplace ergonomics.
Ottobock maintains a robust compliance management system, continually updated to meet legal requirements, including the EU Medical Device Regulation (MDR 2017/745) for its devices. Their digital health platforms, such as 'smart documentation,' are designed to be fully compliant with data privacy regulations like GDPR and HIPAA, ensuring secure storage and transmission of patient information. They also hold certifications like DIN EN ISO 13485 for quality management.
Ottobock provides extensive clinical and technical support through its Professional Clinical Services (PCS) team, offering product certifications, CEU courses, clinical training, and assistance with complex fittings and troubleshooting. They offer dedicated reimbursement services, including expert consulting, guides for medical necessity justification, and the AllClaim program to assist with billing and navigating payer complexities. Additionally, digital tools like 'smart documentation' help generate AI-powered reimbursement justification letters.
Ottobock prioritizes intuitive control in its HMI design, exemplified by AI-powered pattern recognition in prostheses that adapt to the user's muscle signals for natural movements. For exoskeletons, they focus on lightweight, adaptive designs that integrate AI to provide support without restricting natural motion, complemented by apps for ergonomic analysis. Digital solutions like EasyScan and iFab also streamline O&P workflows, enhancing ease of use and efficiency for clinicians.
Ottobock's long-term vision centers on continuous innovation, driven by a dedicated digital research lab focusing on digitalization, 3D printing, and smart sensors to create a comprehensive digital ecosystem for patient care. They actively engage in partnerships with research institutions and technology companies to advance product development, such as with SUITX for exoskeletons. As a global medical technology leader with over a century of experience and a vast international presence, Ottobock demonstrates strong company stability and a commitment to improving quality of life through bionic medical technology and personalized care.

Related Companies

CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]

Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]

OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]

Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]

MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]

allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.